Abstract
The first Cochrane systematic review examining the evidence on screening for prostate cancer was first published in 2006. The 2006 version of the Cochrane review identified two randomised controlled trials (RCTs), drawing the conclusion that there was insufficient evidence to either support, or refute, the use of screening versus no screening in reducing prostate cancer-specific morality. The most recent version of the review, published in 2013, assessed evidence from five RCTs. Based on the evidence from the five RCTs, the authors of the 2013 version concluded that screening did not significantly reduce prostate cancer-specific mortality. Of the five trials included in the 2013 Cochrane review, only two were assessed as being a low risk of bias—the European Randomized Study of Screening for Prostate Cancer (ERSPC) and the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening trial. This chapter discusses the differences between the ERSPC and PLCO trials, and examines what issues may contribute to their conflicting results. It also aims to contextualise results from this most recent Cochrane systematic review and discuss the critique of the Cochrane systematic review raised by Schroder in the chapter entitled, “ERSPC, PLCO studies and critique of Cochrane review 2013”.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Forder P, Gebski V, Keech A (2005) Allocation concealment and blinding: when ignorance is bliss. Med J Aust 182:87–89
Guyatt G, Oxman A, Akl E et al (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383–394
Higgins J, Altman D, Sterne J (2011) Assessing risk of bias in included studies (Chap. 8). In: Higgins J, Green S (eds) Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration. Available from www.cochrane-handbook.org
Ilic D, Neuberger M, Djulbegovic M, Dahm P (2013) Screening for prostate cancer. Cochrane Database Syst Rev 1, article no: CD004720. Doi: 004710.001002/14651858.CD14004720.pub14651853
Ilic D, O’Connor D, Green S, Wilt T (2006) Screening for prostate cancer. Cochrane Database Syst Rev 3, article no: CD004720. Doi: 004710.001002/14651858.CD14004720.pub14651852
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ilic, D. (2014). Screening for Prostate Cancer: Reflecting on the Quality of Evidence from the ERSPC and PLCO Studies. In: Cuzick, J., Thorat, M. (eds) Prostate Cancer Prevention. Recent Results in Cancer Research, vol 202. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45195-9_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-45195-9_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-45194-2
Online ISBN: 978-3-642-45195-9
eBook Packages: MedicineMedicine (R0)